Oral Compliacation after Bone Marrow Transplantation
Authors:
R. Pink 1; Z. Kadlec 3; J. Pazdera 1; P. Michl 1; P. Tvrdý 1; V. Zbořil 1; L. Rajda 2; J. Vondráková 2; E. Faber 2; K. Indrák 2
Authors‘ workplace:
Klinika ústní, čelistní a obličejové chirurgie FN, Olomouc
1; Hematoonkologická klinika FN, Olomouc
2; Klinika zubního lékařství LF UP a FN, Olomouc
3
Published in:
Česká stomatologie / Praktické zubní lékařství, ročník 111, 2011, 3, s. 71-77
Category:
Review Article
Overview
The bone marrow transplantation is a curative method in leukemia, lymphomas, immunodeficient states and solid tumors. Graft versus host disease (GVHD) is a significant complication in patients after bone marrow transplantion, most frequently affected of intestine, liver, skin and oral mucosa. Oral mucosa damage is presented by chronic and acute form of GVHD. The acute form is presented by painful ulcers, lichenoid lesions affecting practically whole oral cavity, while the chronic GVHD is compared to autoimmune diseases such as Sjögren syndrome. GVHD is a major complication of bone marrow transplantation with risk to health a therapeutic result. The treatment is long-term and involve interdisciplinary cooperation.
Key words:
graft versus host disease – bone marrow transplantation – oral mucositis
Sources
1. Antin, J. H., Ferrara, J. L.: Cytokine dysregulation and acute graft-versus-host disease. Blood, 80, 1992, s. 2964–2968.
2. Bauer, D. J., Hood, A. F., Horn, T. D.: Histologic comparison of autologous graft-versus-host reaction and cutaneous eruption of lymphocyte recovery. Arch. Dermatol., roč. 129, 1993, č. 7, s. 855–858.
3. Billingham, R. E.: The biology of graft-versus-host reactions. Harvey Lecture, roč. 62 (1966–1967), s. 21–78.
4. Clark, J. G., Schwartz, D. A., Flournoy, N., Sullivan, K. M., Crawford, S. W., Thomas, E. D.: Risk factors for airflow obstruction in recipient sof bone marrow transplants. Ann. Intern. Med., roč. 107, 1987, s. 648–656.
5. Dreizen, S., McCredie, K. B., Dickie, K. A., Zander, A. R., Peters, L. J.: Oral complications of bone marrow transplantation in adults with acute leukemia. Postgrad. Med., roč. 66, 1979, s. 187–196.
6. Gorin, N. C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A. H., Burnett, A., et al.: Autologous bone marrow transplantation for acute myelocytic leukemia in first remision: a European survey of the role of marrow purging. Blood, roč. 75, 1990, s. 1606–1614.
7. Heimdahl, A., Johson, G., Danielsson, K. H., Lonnquist, B., Sundelin, P., Ringden, O.: Oral condition of patients with leukemia and severe aplastic anemia. Oral Surg. Oral Med. Oral Pathol., roč. 60, 1985, s. 498–504.
8. Kolbinson, D. K., Schubert, M. M., Flournoy, N., Truelove, E. L.: Early oral ganges following bone-marrow transplantation. Oral Surg. Oral Med. Oral Pathol., roč. 66, 1988, s. 130–138.
9. Lawley, T. J., Peck, G. L., Moutsopoulos, H. M., Gratwohl., A. A., Deisseroth, A. B.: Sclerodermia, Sjogren’s-like syndrome, and chronic graft-versus-host disease. Ann. Intern. Med., roč. 87, 1977, s. 707–709.
10. McCullough, J., Hansen, J., Perkins, H., Stroncek, D., Bartsch, G.: The National Marrow Donor Program: how it works, accomplishments to date. Oncology, 1989, 3, s. 63–68.
11. Nash, R. A., Etzioni, R., Storb, R., Furlong, T., Gooley, T., Anasetti, C.: Tacrolimus (FK 506) alone or in combination with methotrexate or methylprednisolon for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study. Blood, roč. 85, 1995, s. 3746–3753.
12. Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., Lietman, P. S.: A randomized double-blind controlled trial in bone-marrow recipients. N. Engl. J. Med., roč. 305, 1981, s. 63–67.
13. Schubert, M. M., Sullivan, K. M., Morton, T. H., Izutsu, K. T., Peterson, D. E., Flournoy, N., et al.: Oral manifestation of chronic graft-versus-host disease. Arch. Intern. Med., roč. 144, 1984, s. 1591–1595.
14. Singhal, S., Mehta, J., Rattenbury, H., Treleaven, J., Powles, R.: Oral pilocarpine hydrochlorid for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood, roč. 85, 1995, s. 1147–1148.
15. Storb, R., Deeg, H. J., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P.: Methotrexate et cyclosporin versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood, roč. 73, 1989, s. 1729–1734.
16. Sullivan, K. M., Shulman, H. M., Storb, R., Weiden, P. L., McDonald, R. P., Whiterspoon, R. P., et al.: Chronic graft-versus-host disease in 52 patients: adverse natural course and succesful treatment with combination immunosuppression. Blood, roč. 57, 1981, s. 267–276.
17. Unanue, E. R., Allen, P. M.: The basis for the immunoregulatory role of macrophages and other accessory cells. Science, roč. 236, 1987, s. 551–557.
18. Vogelsang, G. B., Hess, A. D., Santos, G. W.: Acute graft-versus-host disease: clinical characteristic in the cyclosporine era. Medicine (Baltimore), roč. 67, 1988, č. 3, s. 163–174.
19. Volc-Platzer, B., Honigsmann, H., Hinterberger, W., Wollf, K.: Photochemotherapy improves chronic cutaneous, graft-versus-host disease. J. Am. Acad. Dermatol., roč. 23, 1990, s. 220–228.
20. Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., Thomas, E. D.: Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med., roč. 304, 1981, s. 1529–1533.
Labels
Maxillofacial surgery Orthodontics Dental medicineArticle was published in
Czech Dental Journal
2011 Issue 3
Most read in this issue
- Dry Socket and the Lenght of Healing Depending on the Type of the Treatment - Part One: Classical Treatment
- Frenulectomy in the Treatment of Diastema
- Oral Compliacation after Bone Marrow Transplantation
- Legitimacy of Use of Formocresol in Pediatric Dentistry History and Present of a Well-known Procedure in Pediatric Endodontics